15-hydroxyeicosatrienoic acid has been researched along with 12-hydroxy-5,8,10,14,17-eicospentaenoic acid in 1 studies
| Studies (15-hydroxyeicosatrienoic acid) | Trials (15-hydroxyeicosatrienoic acid) | Recent Studies (post-2010) (15-hydroxyeicosatrienoic acid) | Studies (12-hydroxy-5,8,10,14,17-eicospentaenoic acid) | Trials (12-hydroxy-5,8,10,14,17-eicospentaenoic acid) | Recent Studies (post-2010) (12-hydroxy-5,8,10,14,17-eicospentaenoic acid) |
|---|---|---|---|---|---|
| 13 | 0 | 4 | 13 | 0 | 8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, QX; Cheng, J; Fan, YQ; Liu, BH; Wang, JM; Zhou, H | 1 |
1 other study(ies) available for 15-hydroxyeicosatrienoic acid and 12-hydroxy-5,8,10,14,17-eicospentaenoic acid
| Article | Year |
|---|---|
ACSL4 suppresses glioma cells proliferation via activating ferroptosis.
Topics: Adult; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Coenzyme A Ligases; Down-Regulation; Eicosapentaenoic Acid; Ferroptosis; Gene Expression Regulation, Neoplastic; Glioma; Humans; Hydroxyeicosatetraenoic Acids; Male; Middle Aged; RNA, Small Interfering; Sorafenib | 2020 |